大健康国际2022/23 年度报告

Stock Code: 2211(Incorporated in the Cayman Islands with limited liability ANNUAL REPORT2022/23 COMPANY PROFILE公司簡介 2211+ Universal Health International Group Holding Limited (Stockcode: 2211) (the “Company”, together with its subsidiaries, the“Group”) and its subsidiaries aims at huge market opportunitiesin the universal health industry, strives to be international brandoperator of universal health and become a leading practitioner ofthe strategy of “Internet + Universal Health” as well as a pioneerof the development of ecology in the industry chain by way offinance and capital. 2511,6562,555 The Company is one of the leading pharmaceutical retailer anddistributor in the Northeast of the People’s Republic of China (the“PRC” or “China”). The Group has distinguished pharmaceuticalretail chain network in the Northeast China and it is also the largestprivately operated pharmaceutical distributor in the NortheastChina. As of the date of this annual report, the Group operated251 retail pharmacies, mainly located in the Northeast China, andhad approximately 1,656 active distributors and 2,555 full-timestaff. In addition, the Group has set up five large-scale logisticsstorage centers in Shijiazhuang, Shenyang, Changchun, Harbinand Jiamusi, and has established a high-quality distribution systemacross the country and covering the northeastern region of thePRC. As a basic business segment, the Group’s main product categoriesfor pharmaceutical retail and distribution (including import andexport trade) include prescribed drugs, non-prescribed drugs(Chinese patent medicines, chemical preparations, antibioticsand biochemical drugs), traditional Chinese medicine decoctionpieces, biological products, protein assimilation preparations,peptide hormones, blood products, disinfection products, medicalequipment, family planning supplies (contraceptives and utensils),prepackaged foods, dairy products (including infant formula milkpowder), nutritional foods, health care products, stereotypedpackaging cosmetics, daily necessities, etc. The Group will continue leveraging on the core advantagesof branded products, expanding the scope of cooperation onbranded products, leveraging on business institute training, andproviding more value-added service to employees, customersand consumers. The Group also enriches the product mix byintroducing more health care products based on the expertise inpharmaceutical retail and distribution, so as to promote the conceptof the universal health industry. Meanwhile, the Group activelyexplores upstream ecological chain, covering the construction forChinese herbal medicines base and the production of botanicalcapsule. +++ The Group actively explores online pharmacies, cross-bordere-commerce, influencer marketing and other “Internet+” areas,and advocates the concept of “Specialization+” and introducesthe development concept of “Platform+”. Furthermore, the Groupmaintains upstream and downstream ecosystem leveraging onindustry advantage to cope with the situation of “New Norm” inreal economy, and takes the lead in upgrading and digitalizedtransformation of the industry. CORPORATE INFORMATION公司資料 BOARD OF DIRECTORS Executive Directors: Mr. Chu Chuanfu(Chairman,Chief Executive Officer and Chief operation officer)(Appointed as chairman on 12 December 2022) Mr. Jin Dongkun(Vice chairman)Mr. Zhao ZehuaMr. Jin Dongtao(Resigned as chairman and executive director on12 December 2022) Independent Non-executive Directors: Mr. Cheng Sheung HingMs. Chiang Su Hui SusieMr. Zou Haiyan AUDIT COMMITTEE Mr. Zou Haiyan(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie REMUNERATION COMMITTEE Mr. Cheng Sheung Hing(Chairman)Ms. Chiang Su Hui SusieMr. Jin Dongkun NOMINATION COMMITTEE Mr. Chu Chuanfu(Chairman)(Appointed as chairman on 12 December 2022)Mr. Jin Dongtao(Ceased to be the chairman on12 December 2022)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie AUTHORIZED REPRESENTATIVES Mr. Ge Junming(Ceased on 28 September 2023)Mr. Zhao ZehuaMs. Hui Kit Ying(Appointed on 28 September 2023) COMPANY SECRETARY Mr. Ge Junming(Resigned on 28 September 2023)Ms. Hui Kit Ying(Appointed on 28 September 2023) REGISTERED OFFICE PO Box 309Ugland HouseGrand Cayman, KY1-1104Cayman Islands PO Box 309Ugland HouseGrand Cayman, KY1-1104Cayman Islands HEADQUARTERS 14-1 No. 14-1Bei Yi Zhong RoadTiexi DistrictShenyang CityLiaoning Province, the PRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG 19242404 Room 2404, 24th FloorWorld-Wide House19 Des Voeux Road CentralCentralHong Kong PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE Maples Fund Services (Cayman) Limited Maples Fund Services (Cayman) Limited PO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands PO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands HONG KONG SHARE REGISTRAR AND TRANSFER OFFICE Computershare Hong Kong Investor Services Limited Shops 1712-171617th Floor, Hopewell Centre183 Queen’s Road EastWancha